Should I buy, hold, or sell TBI stock right now?

TrueBlue Inc. (TBI) currently earns a Roarable Rating of D- (Sell — SELL) with 41/100 RQD Confidence. Stretched risk/reward at current multiples (-12% return on capital) under elevated 10-year interest-rate pressure.

What is TBI's 12-month price target and RQD AI Jury consensus?

TBI's 12-month base price target is $9.11 (range $7.11 to $11.58), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Stock Ratings / Consumer Discretionary / TBI

III (71) HCKT (70) RCMT (77) ROMA (30) ⌘ Pro Terminal →

TrueBlue Inc. (TBI) — RQD Stock Rating Cockpit

$9.87 +1.02% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.87

TrueBlue Inc. (TBI) carries a Roarable Rating of D- (Sell) with 41/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $297.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on TBI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is TBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, TrueBlue Inc. (NYSE: TBI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 41/100 at a spot price of $9.87 (+1.02% 1D, market cap $297.4M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 14/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 3/20. Across 1009 tracked Consumer Discretionary issuers, TBI ranks #714 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does TBI compare to III and HCKT in the Consumer Discretionary sector?

▼

Within the Consumer Discretionary sector (Professional Services), TBI carries a Roarable D- (41/100 RQD), trailing P/E of N/A, gross margin of 22.8%, and ROIC of -11.7%. By comparison, III (Information Services Group Inc.) holds a B- grade (71/100 RQD, P/E 31.5x, ROIC 11.2%, cap $295.3M) and HCKT (Hackett Group Inc .) posts a B- grade (70/100 RQD, P/E 24.3x, ROIC 14.8%, cap $318.9M). Among the 5-stock peer group, RCMT leads on earnings multiple (15.6x) while RCMT leads on capital efficiency (46.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for TBI?

▼

Per TBI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-28, CIK 0000768899), TrueBlue Inc. generated $1.62B in revenue (+3.1% YoY), -$48.0M in net income, and -$73.7M in free cash flow against $638.7M in total assets and $65.8M in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $9.87 (-0.01%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (41/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.2% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-7.7% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for TBI)Realized 20D OHLCV Swing Band: ±8.6%

Deterministic 5-Pillar Attribution (41/100 Composite)

🔍 WHY TBI SCORES 41/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (34% of score)

20D Institutional Volume Accumulation (±8.6% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (24% of score)

Altman Z-Score 3.73 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$8.83-6.1% Next Q

Q2 (-2Q)

Grade E$8.29+16.8% Next Q

Q3 (-1Q)

Grade E$9.68+2% Next Q

Current

Grade D-$9.87-7.2% Hist 90D α

Trajectory: E (33) → D- (41)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a TBI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While TBI currently carries a cautious 41/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.39) and Max Pain ($10.36) forces dealer call-delta covering toward $11.58.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $TBI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “TBI Beats Next Quarter EPS Consensus (Dec 27, 2026) & Holds Above 200D SMA”

YES 41%NO 59%Trade / Inspect Odds →

RSI-14 MOMENTUMBULLISH MOMENTUM

60.830 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.73>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

3 / 99-Pt Accounting

52-WEEK LASER RANGE85% OF RANGE

L: $3$9.87H: $11

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: ERQD 4 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 17 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 20 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on TBI

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (20)

-11.7% ROIC with 22.8% gross margin and -24.81% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (50)

Altman-Z 3.73 and Piotroski 3/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (45)

17/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like TBI

✓Established market leader in Consumer Discretionary with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring TBI)

✓Walkthrough of TBI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

TBI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +65.33%⚡ TESTING RESISTANCE

2026-11-03O $9.76H $9.87L $9.76C $9.87VOL 167.3K

RES: $9.84SUP: $8.37SMA50: $9.39SMA200: $6.83

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TBI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 TBI Butterfly Map → + Track TBI →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. +3.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on TBI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TBI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for TBI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (TBI)

Consumer Discretionary Rank #714 of 1009 ⚔️ III vs TBI Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (TBI vs. III, HCKT, RCMT, ROMA)

Industry: Professional Services (48 Tracked Issuers)

Across 1009 tracked Consumer Discretionary securities in the Roarable RQD universe, TrueBlue Inc. (TBI) ranks #714 by composite RQD confidence (41/100, grade D-) and #643 by equity capitalization ($297.4M). Within this direct 5-issuer industry benchmark cohort, RCMT leads on earnings valuation at 15.6x trailing P/E, while RCMT leads on capital efficiency and profitability with 46.0% ROIC and 27.5% gross margin. RCMT currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with TBI at 41/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
TBI ACTIVE TrueBlue Inc.	D-	41/100	—	22.8%	-11.7%	+1.02%	$297.4M	Benchmark Subject
III Information Services Group Inc.	B-	71/100	31.5x	43.1%	11.2%	+2.95%	$295.3M	/iii-vs-tbi →
HCKT Hackett Group Inc .	B-	70/100	24.3x	38.3%	14.8%	+2.96%	$318.9M	/hckt-vs-tbi →
RCMT RCM Technologies Inc.	B+	77/100	15.6x	27.5%	46.0%	-0.65%	$250.4M	/rcmt-vs-tbi →
ROMA Roma Green Finance Limited (Class A)	E	30/100	—	17.1%	—	+1.71%	$383.0M	/roma-vs-tbi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-28 • CIK 0000768899 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-28), TrueBlue Inc. (TBI) reported GAAP revenue of $1.62B (+3.1% vs. FY2024 revenue of $1.57B , and +2319.9% cumulative change since FY2023) , GAAP net income of -$48.0M, operating cash flow of -$58.0M, and free cash flow of -$73.7M (-78.9% YoY). On the balance sheet, TBI closed FY2025 with $638.7M in total assets against $65.8M in total debt (Altman Z-Score: 3.73, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-28	$1.62B	-$48.0M	-$58.0M	-$73.7M	$638.7M	$65.8M
FY2024 (FY)	2024-12-29	$1.57B	-$125.7M	-$17.1M	-$41.2M	$675.4M	$7.6M
FY2023 (FY)	2023-12-31	$66.8M	-$14.2M	$34.8M	$34.8M	—	—

3. TBI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is TBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does TBI compare to III and HCKT in the Consumer Discretionary sector?

What are the biggest fundamental strengths and SEC risk factors for TBI?

Where is TBI trading relative to its 50-day, 200-day, and 52-week technical levels?

TBI last traded at $9.87 (+1.02% on volume of 164,899 shares), positioning the stock +5.11% above its 50-day simple moving average ($9.39) and +44.51% above its 200-day simple moving average ($6.83). Across its 52-week range of $3.18 to $11.03, TBI sits at the 85.2% percentile with a 14-day RSI of 60.8 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.6% ($9.02 to $10.72).

Direct Sub-Reports: TBI RQD Cockpit TBI 12M Forecast TBI Earnings & Move TBI Dividends & DRIP TBI Insiders & 13F TBI Whale Options TBI Profit Sankey TBI News & Why

ROARABLE RATING BRIEF • RQD 41/100 (D-) ✓ SEC XBRL & RQD VERIFIED

TBI — TrueBlue Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-28

1. Roarable Rating Brief: What This Means to a Prospective Investor

TrueBlue Inc. (TBI) earns a live Roarable RQD composite score of 41/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $9.87 (+1.02% 1D, market capitalization $297.4M).

Fundamental Cash Engine (4/20): Anchored by return on invested capital (ROIC) of -11.7%, gross margin of 22.8%, operating margin of -2.9%, and free cash flow yield of -24.81%.
Whale 13F & Options Flow (14/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (10/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of 3.73, Piotroski F-Score of 3/9, and Debt/Equity of 0.24x.

2. Business Model, Unit Margins & SEC Financial Trajectory

And profile, TrueBlue Inc. Is a NYSE-listed issuer classified in the Consumer Discretionary sector and Professional Services industry. Per the market data, the company reports a gross margin of 22.8%, an operating margin of -2.9%, and a net margin of -3%. — describes its specific product lines, customer base, or revenue model, so the mechanics of how it earns revenue cannot be detailed from the sources provided.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-28), TrueBlue Inc. (TBI) reported $1.62B in annual revenue (up from $1.57B in FY2024, +3.1% YoY) and -$48.0M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($66.8M revenue, -$14.2M net income) through FY2025, TBI scaled operating cash flow to -$58.0M and free cash flow to -$73.7M, backed by $638.7M in total assets against $65.8M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (D- • RQD 41/100): Established market leader in Consumer Discretionary with deep daily trading liquidity. Free cash flow yield of -24.81% and institutional whale pillar of 14/20. With Fundamental Cash Engine at 4/20 and Institutional Whale Flow at 14/20, sustained execution supports upside toward the upper end of the $3.18 – $11.03 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -2.9% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies are therefore — The only sector-level context in the sources is the news reference to tech visa rules tightening, which the news feed ties to staffing stocks generally.

Key Question #1: Can TBI sustain or expand its -2.9% operating margin and -11.7% ROIC against Professional Services peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $1.62B and free cash flow of -$73.7M, how will capital allocation balance growth reinvestment against $65.8M in total debt?
Key Question #3: How sensitive is TBI's equity valuation to Consumer Discretionary capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

TBI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for TrueBlue Inc. (TBI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to TBI Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 23h ago

TrueBlue to Participate in J.P. Morgan Ultimate Services Investor Conference (USIC)

Yahoo Finance report covering TrueBlue Inc. (TBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 1d ago

TrueBlue, Inc. Estimates – NYSE:TBI

TradingView report covering TrueBlue Inc. (TBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

TrueBlue Appoints Elizabeth Castro Gulacsy to Board of Directors

Yahoo Finance report covering TrueBlue Inc. (TBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.siam.in/ • 1d ago

TrueBlue Inc. (TBI) Climbs 3.38% to $8.57 as Staffing Shares Push Toward Resistance - Factor Rotation

https://www.siam.in/ report covering TrueBlue Inc. (TBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Simply Wall Street • 1d ago

3 US Staffing Stocks Investors Are Screening As Tech Visa Rules Tighten

Simply Wall Street report covering TrueBlue Inc. (TBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ad-hoc-news.de • 1d ago

TrueBlue stock: CEO filing details 3,908 shares withheld

ad-hoc-news.de report covering TrueBlue Inc. (TBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.siam.in/ • 1d ago

TrueBlue (TBI) Rallies 5.90% to $9.34 as Staffing Stock Pushes Toward Resistance - Gap and Reverse

https://www.siam.in/ report covering TrueBlue Inc. (TBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Simply Wall St • 1d ago

3 Labor Market Stocks Riding The AI Reskilling Shift

Simply Wall St report covering TrueBlue Inc. (TBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

TBI Bull vs. Bear Conversation Board — What's Your Call at $9.87?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON TBI 🐻 33% BEARISH CONVICTION

CA CashFlowKing RQD DEBATE OPENER • FCF Compounder Hunter 🐂 BULLISH 🎯 Target: $11.33 (+16.0%)

📌 Pinned Debate

Revenue grew from $1.57B to $1.62B while the net loss narrowed from -$125.7M to -$48.0M.

Picked up a starter position in TBI in my $100K Virtual Cash book at $9.77. Revenue grew from $1.57B to $1.62B while the net loss narrowed from -$125.7M to -$48.0M.. Trading inside a $3.18–$11.03 52-week range with -24.81% FCF yield gives solid downside support if Professional Services multiples expand this quarter.

EarningsSniper 🐂 BULL

@RedlineAuditor Shorting a 14/20 institutional whale-flow stock at $9.77 is dangerous when funds are rotating into Consumer Discretionary.

RE RedlineAuditor RQD DEBATE OPENER • Accounting Quality Watch 🐻 BEARISH 🎯 Target: $7.43 (-24.0%)

Spot @ $9.77

ROIC of -11.7% and FCF of -$73.7M against rising debt of $65.8M signal continuing cash burn.

ROIC of -11.7% and FCF of -$73.7M against rising debt of $65.8M signal continuing cash burn.. Look at the math on TBI: paying current EV/EBITDA multiples for -11.7% ROIC and -2.9% operating margins leaves zero margin of safety if Professional Services demand softens. I'd wait for a retest of $8.60 before getting long.